In this week’s View, Dr. Eagle explores a study looking at the long-term safety and efficacy of the subcutaneous implantable cardioverter-defibrillator system. He then explores combination lipid-lowering therapy in patients undergoing PCI versus statin therapy alone. Finally, Dr. Eagle looks at an important article on raced-based differences in the management of ST segment elevation myocardial infarction.

Twitter Links:

• Dr. Kim Eagle: @keaglemd
• American College of Cardiology: @ACCinTouch

Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Stable Ischemic Heart Disease, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and SIHD, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Interventions and Coronary Artery Disease, Interventions and Vascular Medicine, Chronic Angina

Keywords: EaglesEyeView, Arrhythmias, Cardiac, Bradycardia, Defibrillators, Implantable, Heart Failure, Pacemaker, Artificial, Secondary Prevention, Shock, Tachycardia, Ventricular, Ventricular Fibrillation, Atherosclerosis, Coronary Artery Disease, Diabetes Mellitus, Drug-Eluting Stents, Dyslipidemias, Ezetimibe, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Medication Adherence, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Rosuvastatin Calcium, Stroke, African Americans, Electrocardiography, Emergency Medical Services, Ethnic Groups, Healthcare Disparities, Hispanic Americans, Race Factors, Socioeconomic Factors, ST Elevation Myocardial Infarction

< Back to Listings